Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that…
Medical - Instruments & Supplies
CA, Vaughan [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Bausch + Lomb Corporation's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2022 | - | 1.066 | - | 3,740 | - | 373 | - | 717 | - | 301 | - | 1,430 |
| 2023 | 0.0429 | 0.667 | 3,768 | 4,077 | 15 | 228 | 457 | 782 | 220 | 328 | 1,478 | 1,560 |
| 2024 | -0.7400 | 0.599 | 4,146 | 4,771 | -260 | 209 | 601 | 915 | 204 | 384 | 1,736 | 1,825 |
| 2025 | - | 0.845 | - | 5,062 | - | 296 | - | 971 | - | 407 | - | 1,936 |
| 2026 | - | 1.086 | - | 5,355 | - | 2.F4X/td> | - | 2.F41/td> | - | 2.F41 | - | 2.F41 |
| 2027 | - | 1.253 | - | 5,554 | - | 1.F5X/td> | - | 1.F51/td> | - | 1.F51 | - | 1.F51 |
| 2028 | - | 1.430 | - | 5,749 | - | 0.F6X/td> | - | 0.F61/td> | - | 0.F61 | - | 0.F61 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
Overweight
Prev. Grade
Equal-Weight
Nov. 6, 2024
Overweight
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
Underweight
Prev. Grade
Underweight
Nov. 6, 2024
Underweight
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
-69.083% $13.63 · MISS
Nov. 6, 2024Price Then
$19.81
Price Target
$33.36
Price Now
$19.73